Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Liposomes in haematology.

A Gray1, J Morgan

  • 1Department of Haematology, Princess Margaret Hospital, Swindon, Wiltshire, UK.

Blood Reviews
|December 1, 1991
PubMed
Summary
This summary is machine-generated.

Liposomes, drug delivery vehicles, show promise in cancer treatment by reducing toxicity. While efficacy may not significantly increase, reduced side effects are a key benefit for liposomal formulations like amphotericin B and doxorubicin.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drug management of TB in the intensive care setting: an international multicentre study.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2025
Same author

Prevalence of transthyretin cardiac amyloidosis in undifferentiated heart failure with preserved ejection fraction.

ESC heart failure·2024
Same author

Patient evaluation of Klick, a technology-enabled, nurse-delivered HIV outpatient pathway.

HIV medicine·2024
Same author

The societal economic impact of vision impairment in adults 40 years and above: findings from the National Eye Survey of Trinidad and Tobago.

Eye (London, England)·2023
Same author

Urgent appeal to allow all professional nurses and midwives to prescribe pre-exposure prophylaxis (PrEP) in South Africa.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2023
Same author

Proactive care post-discharge to reduce 30 day readmissions to hospital.

The International journal of risk & safety in medicine·2022

Area of Science:

  • Biochemistry
  • Nanotechnology
  • Pharmacology

Background:

  • Liposomes, lipid bilayer models, have been studied for decades.
  • Their potential as drug delivery vehicles was recognized early on.
  • Clinical applications have been slow due to challenges like reticuloendothelial system uptake.

Purpose of the Study:

  • To review the development of liposomes as drug carriers, particularly for malignancy.
  • To discuss the challenges and successes in clinical applications of liposomal drug delivery.
  • To evaluate the impact of liposomal encapsulation on drug efficacy and toxicity.

Main Methods:

  • Review of in vitro and animal studies on liposomal drug delivery.
  • Analysis of clinical trial data for liposomal formulations.

Related Experiment Videos

  • Examination of pharmacokinetic and pharmacodynamic properties of liposomes.

    • Main Results:

    • Liposomal drug delivery faces challenges with reticuloendothelial system uptake and extravasation.
    • Amphotericin B is the first licensed parenteral liposomal agent.
    • Liposomal doxorubicin is in clinical trials, showing reduced toxicity.
    • Liposomal encapsulation may not significantly enhance efficacy but greatly reduces toxicity.

    Conclusions:

    • Liposomes offer a viable strategy for reducing drug toxicity.
    • Clinical translation of liposomes has been hindered by biological barriers.
    • Targeted delivery and reduced side effects are key advantages of liposomal formulations.